Aditi Gupta, MD
Nephrology · Kansas City, KSNPI 1154542769
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $11,643 of the $16,367 with a category attached, or 71.1%. Bayer accounts for 78.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $9,984 and has fallen 100.0% since, to $4 in 2025. Among nephrology clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $606.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$13K
- Veloxis Pharmaceuticals, Inc.$3K
- Abbott$20
- Novartis$14
- Travere Therapeutics, Inc.$4
Across 65 payments — averaging $8169.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Veloxis Pharmaceuticals, Inc.$251K
- Novartis$141K
- Bayer$139K
What the payments were for
- Consulting fees$3,45021%
- Speaking & faculty fees$11,64371%
- Travel & lodging$8155%
- Food & beverage$4593%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 23 | $12,878 |
| Veloxis Pharmaceuticals, Inc. | 1 | $3,450 |
| Abbott | 1 | $20 |
| Novartis | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,367 in reported general payments places this provider in the 95th percentile of 55 nephrology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 20 | $1,180 |
| Mycophenolic AcidMycophenolate Sodium | 25 | $797 |
| Prednisone | 55 | $583 |
| Amlodipine Besylate | 45 | $294 |
| Carvedilol | 37 | $236 |
| Allopurinol | 29 | $183 |
| Losartan Potassium | 22 | $129 |
| Pantoprazole Sodium | 12 | $122 |
| Lisinopril | 22 | $91 |
| Omeprazole | 12 | $78 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Kansas City
- Alan YuKansas City$16K
- Ahmad TuffahaKansas City$15K
- Diane CibrikKansas City$12K
- Duncan JohnstoneKansas City$4K
- Amna IlaheKansas City$2K
- Sri YarlagaddaKansas City$1K
- Reem MustafaKansas City$1K
- Itunu OwoyemiKansas City$931
- Andrew StingoKansas City$637
- Venu NairKansas City$436
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.